April 24, 2013
Mayo Clinic and Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the first patient has been enrolled in the first clinical trial of rHIgM22, a remyelinating antibody being studied for the treatment of multiple sclerosis (MS)… “This remyelinating antibody, if successful in clinical trials and approved, would be a novel approach to treating people with […]
Tags: Acorda Therapeutics, antibody, chronic neurologic deficits, clinical trial, Dr. Moses Rodriguez, MS, multiple sclerosis, rHIgM22, Wall Street Journal
April 22, 2013
Study to Treat Deadly Form of Thyroid Cancer Shows Promise, Mayo Clinic Says
A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida…”This is good news, because we did not reach a maximum tolerated dose, meaning that the drug is well tolerated,” says the […]
Tags: anaplastic thyroid cancer, clinical trial, Dr. Robert Smallridge, HealthCanal, thyroid cancer, treatment
March 18, 2013
Mayo Clinic to hold trial for BrainStorm’s ALS stem cell therapy
BrainStorm Cell Therapeutics said the Mayo Clinic in Minnesota has agreed to conduct a clinical trial of the company’s adult stem cell treatment for ALS. The Mayo Clinic is the third leading U.S. clinical site to sign a letter of understanding, following the University of Massachusetts and Massachusetts General, BrainStorm said on Monday. Additional Coverage: […]
Tags: A.L.S., BrainStorm Cell Therapeutics, clinical trial, Reuters, stem cell therapy, stem-cell
December 3, 2009
Record numbers of Ontarians are being sent to the U.S. by their government for routine health care that should be available at home. At 34, Lisa Nancarrow was told her only option was to go home and prepare to die…T hat was until her family found a clinical trial at the Mayo Clinic […]
Tags: Canada, clinical trial, Ontario